By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute is continuing its Innovative Molecular Analysis Technologies Program (IMAT), providing funding for projects that focus on the inception and early development of tools that could significantly impact cancer research.

The funding also could support emerging technologies aimed at transforming research or clinical care, and efforts that aim to advance biospecimen storage, collection, processing, and handling.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.